Your browser doesn't support javascript.
loading
Development of an Interleukin-1ß Vaccine in Patients with Type 2 Diabetes.
Cavelti-Weder, Claudia; Timper, Katharina; Seelig, Eleonora; Keller, Cornelia; Osranek, Martin; Lässing, Ute; Spohn, Gunther; Maurer, Patrik; Müller, Philipp; Jennings, Gary T; Willers, Joerg; Saudan, Philippe; Donath, Marc Y; Bachmann, Martin F.
Afiliación
  • Cavelti-Weder C; Department of Endocrinology, Diabetes, and Metabolism, University Hospital of Basel, Basel, Switzerland.
  • Timper K; Department of Endocrinology, Diabetes, and Metabolism, University Hospital of Basel, Basel, Switzerland.
  • Seelig E; Department of Endocrinology, Diabetes, and Metabolism, University Hospital of Basel, Basel, Switzerland.
  • Keller C; Department of Endocrinology, Diabetes, and Metabolism, University Hospital of Zurich, Zurich, Switzerland.
  • Osranek M; Department of Endocrinology, Diabetes, and Metabolism, University Hospital of Zurich, Zurich, Switzerland.
  • Lässing U; Cytos Biotechnology AG, Schlieren, Switzerland.
  • Spohn G; Cytos Biotechnology AG, Schlieren, Switzerland.
  • Maurer P; Cytos Biotechnology AG, Schlieren, Switzerland.
  • Müller P; Cytos Biotechnology AG, Schlieren, Switzerland.
  • Jennings GT; Cytos Biotechnology AG, Schlieren, Switzerland.
  • Willers J; Cytos Biotechnology AG, Schlieren, Switzerland.
  • Saudan P; Cytos Biotechnology AG, Schlieren, Switzerland.
  • Donath MY; Department of Endocrinology, Diabetes, and Metabolism, University Hospital of Basel, Basel, Switzerland.
  • Bachmann MF; Cytos Biotechnology AG, Schlieren, Switzerland.
Mol Ther ; 24(5): 1003-12, 2016 05.
Article en En | MEDLINE | ID: mdl-26686385
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas / Diabetes Mellitus Tipo 2 / Interleucina-1beta / Anticuerpos Neutralizantes / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2016 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas / Diabetes Mellitus Tipo 2 / Interleucina-1beta / Anticuerpos Neutralizantes / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2016 Tipo del documento: Article País de afiliación: Suiza